Price:
Rs. 9,330.00
Sample Type: BLOOD
Fasting Not Required
Notes: L0101
Frequently Asked Questions (FAQ's):
What does the Leukemia CMPD Panel test detect?
It identifies key gene mutations linked to chronic myeloproliferative disorders, aiding in diagnosis and treatment planning.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced molecular analysis techniques, including PCR and sequencing, to accurately detect mutation profiles.
Who should take this test?
Patients with unexplained high blood counts, suspected CMPD, or those being evaluated for targeted therapy or bone marrow transplant.
What type of sample is required?
A blood sample collected in an EDTA tube.
How long does Metropolis Healthcare take to release results?
Typically within 10–14 working days, depending on the complexity of the case.
How do the results help in treatment decisions?
They guide clinicians in therapeutic selection, predicting treatment response, and identifying high-risk or progressive disease.
Is this test useful for monitoring disease progression?
Yes, it can help in tracking mutation changes, relapse risk, and therapy effectiveness over time.
Does Metropolis Healthcare offer expert interpretation?
Yes, experienced hematopathologists and molecular experts at Metropolis Healthcare provide detailed clinical guidance with the report